Impact of EU label changes and pregnancy prevention programme for medicinal products containing valproate and related substances: risk awareness and adherence (ValproateRiskAware)

24/01/2020
08/12/2025
EU PAS number:
EUPAS32405
Study
Finalised
Documents
Study protocol
Initial protocol
English (634.51 KB - PDF) View document
Study results
Study results
English (196.49 KB - PDF) View document
Study report
Study report
English (2.29 MB - PDF) View document
Other information